ISPOR 2022

May 15-18, 2022 | Washington, USA

We are excited to announce that we will be exhibiting at ISPOR 2022 in Washington, DC. Leading industry event for health economics and outcomes research experts, ISPOR 2022 encourages open discussion of the challenges and opportunities of the emerging patient-driven healthcare system and HEOR’s role in shaping its development.

Contact our delegates or find us at the booth 406 to learn more about Alira Health’s offerings.

Events
Published on:
May 10, 2022
Our posters

Join us as we present our posters during ISPOR 2022:

Monday, May 16
Session 2: 3:00PM – 6:30PM | Presentation: 5:30PM – 6:30PM
Adoption and Use of a Digital Health Tool (HEALTH STORYLINES) for Self Management By People with Schizophrenia
Willmon R, Gorla J, Jardine N, Adams J

Tuesday, May 17
Session 3: 9:45AM – 1:15PM | Presentation: 12:15PM – 1:15PM
A Digitally Enabled Care and Real World Evidence (RWE) Research Program Among Individuals with Asthma and COPD during the COVID-19 Pandemic
Willmon R, George O, Selvarajah S, Adams J, Soyao G, Hart M, Gardner DD, Winders T

Tuesday, May 17
Session 4: 3:00PM – 6:30PM | Presentation: 5:30PM – 6:30 PM
The Role of Patient Engagement in the Adoption and Use of a Mobile Application (HEALTH STORYLINES) Among Men with Prostate Cancer
Willmon R, Selvarajah S, Jardine N, Adams J

Tuesday, May 17
Session 4: 3:00PM – 6:30PM | Presentation: 5:30PM – 6:30 PM
Recommendations on best practices for RWD study design to support HTA decision making in Europe
Oscar Dumoulin, Alexa Vidalis, Jean-Francois Ricci, Catia C Proenca

Wednesday, May 18
Session 5: 9:00AM – 12:45PM | Presentation: 9:00AM – 10:00AM
Logistical and Financial Challenges in the Adoption of CAR-T Therapies: A Narrative Review
Anna Ulrich, Beatriz Massó, Celia Sathi, Claudia Leopaldi, Jungyoon Moon, Marco Lucchino, and Pepi Hurtado

Wednesday, May 18
Session 5: 9:00AM – 12:45PM | Presentation: 9:00AM – 10:00AM
Quality of Life (QoL) in patients with aHCC in clinical trials and HTA implications
Jung Yoon Moon, Pepi Hurtado, Marco Lucchino, Celia Sathi, Alexa Vidalis, Elise Demont, Giuseppe Gulotta, and Oscar Dumoulin

Our delegates

Jean-Francois Ricci

Chief Access Officer, Alira Health
Pepi

Pepi Hurtado

Vice President, Global Market Access, Alira Health

Jung Yoon Moon

Senior Consultant, Global Market Access, Alira Health

Anna Ulrich

Consultant, Global Market Access, Alira Health

Elvan Sen

Associate Consultant, MedTech Market Access, Alira Health
Renee Willmon

Renee Willmon

Senior Director, Evidence and Outcomes, Self Care Catalysts, an Alira Health company

Shameni Selvarajah

Associate Manager, Scientific Evidence, Self Care Catalysts, an Alira Health company

Kelly Mehrer

Commercial Office Life Sciences, Self Care Catalysts, an Alira Health company

Mace Whiting

Business Development Manager, Self Care Catalysts, an Alira Health company

Tim LaCroix

Lead, Life Sciences, Decentralized Studies & RWE Digital Strategy, Self Care Catalysts, an Alira Health company
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.